glp 1 a1c lowering 55 - Comparative Analysis of and Weight Reduction Potential of Subcutaneous GLP-1 Receptor Agonists in a Real-World Setting Novel GLP-1 agonist dulaglutide wins

And the researchers did not observe the liver toxicity that had plagued some earlier small molecule GLP-1 drugs

Patients with Crohn's disease who are considering or currently prescribed GLP-1 receptor agonists for diabetes or weight management should have comprehensive discussions with their gastroenterology team

PMCID: PMC2987380 Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, Maguire JI, Tasman W, Prockop DJ

The neurodevelopmental consequences of brain injury include death, cerebral palsy, severe intellectual disabilities, blindness, deafness, and a number of minor behavioral and cognitive deficits

Biomolecules 9 (8), 356